07.12.2012 Views

AAHS ASPN ASRM - 2013 Annual Meeting - American Association ...

AAHS ASPN ASRM - 2013 Annual Meeting - American Association ...

AAHS ASPN ASRM - 2013 Annual Meeting - American Association ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>ASRM</strong> Concurrent Scientific Paper Presentatons C-1<br />

A New Composite Tissue Allograft Transplantation Model for Reconstruction of the Head and Neck Defects and<br />

Long Term Survival Permitted by Donor Specific Chimerism Under Low Dose Cyclosporine A Treatment<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Yalcin Kulahci; Aleksandra Klimczak; Maria Siemionow; The Cleveland Clinic Foundation<br />

Background:<br />

Extensive head and neck deformities including bone and soft tissue defects are always challenging for reconstructive surgeons. The purpose of this study was<br />

to extend application of the face/scalp transplantation model in rat by incorporation of the vascularized mandible, masseter and tongue, based on the same<br />

vascular pedicle, as a new reconstructive option for extensive head and neck deformities with large soft and bone tissue defects.<br />

Methods:<br />

A total of 12 composite osseomusculocutaneous hemiface/mandible-tongue transplantations were performed in two experimental groups. Group 1 isotransplantation<br />

between Lewis rats served as control without treatment (n=6). Group 2 (n=6) composite hemiface/mandible-tongue transplants were performed<br />

across MHC barrier between Lewis-Brown Norway (LBN, RT11+n) donors and Lewis (RT11) recipients. Hemifacial flaps including hemimandibular bone, masseter<br />

muscle and tongue were dissected on the same pedicle of external carotid artery and jugular vein and were transplanted to the donor inguinal region.<br />

All allogenic transplant recipients received 16mg/kg/day of CsA monotheraphy tapered to 2 mg/kg/day and maintained at this level thereafter. All animals were<br />

monitored for sign of allograft rejection such as erythema, edema, hair loss, desquamation. Flap angiography and CT scan evaluated allograft viability. Flow<br />

cytometry assessed donor-specific chimerism for MHC class I- RT1n antigen. H&E staining revealed bone histology, hemotopoietic activity and tested inflammatory<br />

response and grade of allograft rejection.<br />

Results:<br />

Isograft controls survived indefinitely. Six hemiface/mandible-tongue allotransplants survived up to 200 days (still under observation). Flap angiography demonstrated<br />

intact vascular supply to the bone. No signs of rejection and no flap loss were noted. CT scan and bone histology confirmed viability of bone components<br />

of the composite allografts. Viability of tongue was confirmed by pink color, bleeding after puncture and histology. H+E staining determined the presence<br />

of viable bone marrow cells within transplanted mandible. Donor-specific chimerism at day 100 posttransplant was established for by presence of donor<br />

T-cells (2.7% CD4/RT1n, 1.2% CD8/RT1n) and B-cells (11.5% CD45RA/RT1n).<br />

Conclusions:<br />

We have introduced a new model of composite osseomusculocutaneous hemiface/mandible-tongue allograft transplant. Long-term allograft acceptance was<br />

accompanied by presence of donor specific chimerism supported by vascularized bone marrow transplant of the mandibular component. This model may serve<br />

as a new reconstructive option for coverage of the extensive head and neck deformities involving large bone and soft tissue defects performed in one-stage<br />

surgical procedure.<br />

Potential Approaches to Face Harvest for Face Transplantation<br />

Institution where the work was prepared: Duke University Medical Center, Durham, NC, USA<br />

Alessio Baccarani, MD; Keith E. Follmar; Jeffrey R. Marcus; Detlev Erdmann; L. Scott Levin; Duke University<br />

Background:<br />

Total face transplantation has begun to emerge as a reconstructive option in the treatment of patients with massive facial disfigurement. The challenges associated<br />

with immunosuppression and the ethical issues surrounding face transplantation are substantial. One of the most significant technical questions that<br />

remains to be answered before the first total face transplant can be performed is how a facial allograft would be harvested and what tissues it would include.<br />

We present two novel face harvesting techniques based on our understanding of the vascular anatomy.<br />

Methods:<br />

The first technique harvests the skin and soft tissue of the face by dissecting in a subgaleal, sub-SMAS, subplatysmal plane. The second technique harvests the<br />

entire soft tissue and bony structure of the face by dissecting in a subperiosteal plane and harvesting the bones of the midface by performing a Le Fort III<br />

osteotomy. These techniques were performed on fresh human cadavers that had been perfused with latex.<br />

Results:<br />

Each face was harvested successfully as a bipedicled flap based on the external carotid arteries, the external jugular veins, and the facial veins. The sub-SMAS<br />

flap appeared to be well perfused by the external carotid system throughout. The subperiosteal Le Fort III flap appeared to be well perfused everywhere except<br />

for portions of the zygomatic arch and the sphenoid bone.<br />

Conclusions:<br />

Each of these two techniques is a theoretically viable approach to face harvesting for face transplantation and they address different reconstructive needs.<br />

Substantial challenges remain before face transplantation can become a viable reconstructive option.<br />

161

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!